The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 109,318,155 | 9,699,925 | SH | SOLE | 9,699,925 | 0 | 0 | |||
CINCOR PHARMA INC | COM | 17240Y109 | 4,711,863 | 383,390 | SH | SOLE | 383,390 | 0 | 0 | |||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 1,773,022 | 1,866,339 | SH | SOLE | 1,866,339 | 0 | 0 | |||
HARMONY BIOSCIENCES HLDGS IN | COM | 413197104 | 57,050,320 | 1,035,396 | SH | SOLE | 1,035,396 | 0 | 0 | |||
IMPEL PHARMACEUTICALS INC | COM | 45258K109 | 10,349,216 | 2,759,791 | SH | SOLE | 2,759,791 | 0 | 0 | |||
PHARVARIS N V | COM | N69605108 | 25,837,988 | 2,296,710 | SH | SOLE | 2,296,710 | 0 | 0 | |||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 113,503,765 | 3,461,536 | SH | SOLE | 3,461,536 | 0 | 0 |